Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:1999-2003
Published online before print April 30, 2009, doi: 10.1161/STROKEAHA.108.546150
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/6/1999    most recent
STROKEAHA.108.546150v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Famakin, B. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Famakin, B. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ACETYLSALICYLIC ACID
*WARFARIN
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Other arteriosclerosis
Right arrow Acute Cerebral Infarction
Right arrow Risk Factors for Stroke

(Stroke. 2009;40:1999.)
© 2009 American Heart Association, Inc.


Original Contributions

Causes and Severity of Ischemic Stroke in Patients With Symptomatic Intracranial Arterial Stenosis

Bolanle M. Famakin, MD; Marc I. Chimowitz, MBChB; Michael J. Lynn, MS; Barney J. Stern, MD; Mary G. George, MD for the WASID Trial Investigators

From the Department of Neurology (B.M.F., M.I.C., B.J.S.), Emory University School of Medicine, and the Department of Biostatistics (M.J.L., M.G.G.), The Rollins School of Public Health of Emory University, Atlanta, Ga.

Correspondence to Dr Bolanle M. Famakin, National Institutes of Health, National Institute of Neurological Disorders and Stroke, Stroke Branch, 49 Convent Drive, Building 49, Room 2A51, MSC 4476, Bethesda, MD 20892. E-mail famakinb{at}ninds.nih.gov

Background and Purpose— There are limited data on the causes and severity of subsequent stroke in patients presenting initially with TIA or stroke attributed to intracranial arterial stenosis.

Methods— We evaluated the location, type (lacunar vs nonlacunar), cause, and severity of stroke in patients who had an ischemic stroke endpoint in the Warfarin Aspirin Symptomatic Intracranial Disease (WASID) trial.

Results— Of the 569 patients enrolled in the WASID trial, 106 patients (18.6%) had an ischemic stroke during a mean follow-up of 1.8 years. Stroke occurred in the territory of the symptomatic artery in 77 (73%) of 106 patients. Among the 77 strokes in the territory, 70 (91%) were nonlacunar and 34 (44%) were disabling. Stroke out of the territory of the symptomatic artery occurred in 29 (27%) of 106 patients. Among these 29 strokes, 24 (83%) were nonlacunar, 14 (48%) were attributed to previously asymptomatic intracranial stenosis, and 9 (31%) were disabling.

Conclusions— Most subsequent strokes in patients with symptomatic intracranial artery stenosis are in the same territory and nonlacunar, and nearly half of the strokes in the territory are disabling. The most commonly identified cause of stroke out of the territory was a previously asymptomatic intracranial stenosis. Penetrating artery disease was responsible for a low number of strokes.


Key Words: acute stroke • intracranial stenosis • lacunar infarcts • severity • WASID